Knight Jeff E.
Insider CIK 1881007 · CRNX Chief Operating Officer · ALXO Chief Dev & Operating Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ALXO ALX ONCOLOGY HOLDINGS INC | A Award deriv | 2026-04-16 | 2026-04-17 | 800,000 | — | $0 | 800,000 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise deriv | 2026-04-08 | 2026-04-10 | 49,474 | — | $0 | 63,027 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise deriv | 2026-04-08 | 2026-04-10 | 19,336 | — | $0 | 65,977 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise deriv | 2026-04-08 | 2026-04-10 | 9,624 | — | $0 | 10,589 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2026-04-08 | 2026-04-10 | 85,163 | $40.10 | $3.42M | 105,289 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise | 2026-04-08 | 2026-04-10 | 49,474 | $23.98 | $1.19M | 161,492 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise | 2026-04-08 | 2026-04-10 | 9,624 | $20.02 | $192.7K | 171,116 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise | 2026-04-08 | 2026-04-10 | 19,336 | $19.64 | $379.8K | 190,452 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2026-03-16 | 2026-03-18 | 5,950 | $37.11 | $220.8K | 115,979 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2026-03-16 | 2026-03-18 | 3,961 | $37.77 | $149.6K | 112,018 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award deriv | 2026-02-23 | 2026-02-25 | 55,000 | — | $0 | 55,000 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award | 2026-02-23 | 2026-02-25 | 34,000 | — | $0 | 121,929 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2025-03-19 | 2025-03-21 | 6,801 | $34.17 | $232.4K | 87,852 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2025-03-19 | 2025-03-21 | 361 | $34.83 | $12.6K | 87,491 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award deriv | 2025-02-20 | 2025-02-24 | 65,000 | — | $0 | 65,000 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award | 2025-02-20 | 2025-02-24 | 43,000 | — | $0 | 94,653 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2024-11-22 | 2024-11-26 | 501 | $56.52 | $28.3K | 51,653 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise deriv | 2024-07-15 | 2024-07-17 | 17,499 | — | $0 | 112,501 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise deriv | 2024-07-15 | 2024-07-17 | 2,887 | — | $0 | 20,213 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise deriv | 2024-07-15 | 2024-07-17 | 5,687 | — | $0 | 85,313 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise | 2024-07-15 | 2024-07-17 | 5,687 | $19.64 | $111.7K | 78,653 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2024-07-15 | 2024-07-17 | 27,000 | $55.00 | $1.49M | 51,653 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise | 2024-07-15 | 2024-07-17 | 17,499 | $23.98 | $419.6K | 70,079 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise | 2024-07-15 | 2024-07-17 | 2,887 | $20.02 | $57.8K | 72,966 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2024-06-26 | 2024-06-28 | 956 | $44.38 | $42.4K | 52,580 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise deriv | 2024-03-22 | 2024-03-26 | 30,000 | — | $0 | 130,000 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | M Exercise | 2024-03-22 | 2024-03-26 | 30,000 | $23.98 | $719.4K | 84,939 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2024-03-22 | 2024-03-26 | 2,359 | $45.39 | $107.1K | 52,580 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2024-03-22 | 2024-03-26 | 30,000 | $44.22 | $1.33M | 54,939 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | F Tax w/h | 2024-03-18 | 2024-03-20 | 4,283 | $38.14 | $163.4K | 54,939 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award deriv | 2024-03-04 | 2024-03-06 | 87,000 | — | $0 | 87,000 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award | 2024-03-04 | 2024-03-06 | 23,000 | — | $0 | 59,222 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | F Tax w/h | 2023-03-16 | 2023-03-17 | 587 | $17.12 | $10.0K | 34,400 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award deriv | 2023-03-01 | 2023-03-03 | 91,000 | — | $0 | 91,000 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award | 2023-03-01 | 2023-03-03 | 29,500 | — | $0 | 34,987 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | S Sale | 2022-07-26 | 2022-07-29 | 1,152 | $20.70 | $23.8K | 4,950 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | J Other | 2022-05-20 | 2022-07-29 | 1,152 | $17.44 | $20.1K | 6,102 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award deriv | 2022-02-28 | 2022-03-02 | 23,100 | — | $0 | 23,100 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award | 2022-02-28 | 2022-03-02 | 4,950 | — | $0 | 4,950 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award deriv | 2021-09-01 | 2021-09-02 | 160,000 | — | $0 | 160,000 | SEC↗ |